A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

20245 citationsJournal Articlegold Open Access

Authors

EudraCT Number 2022-001709-35 (COV-2022-001).

Good health and well-being

Published in: Infectious Diseases and Therapy

Volume 13, Issue 1, pp. 173-187

Field-Weighted Citation Impact: 1.98